SCHEMBL8556094

SCHEMBL8556094

CCC(c1cccc2c1C(=O)NC2=O)C1COCCN1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 3/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
MAPK10 P53779 1/20 0.33
GAA P10253 1/20 0.33
GSK3B P49841 2/20 0.32
GSK3A P49840 1/20 0.32
CDK5 Q00535 1/20 0.32
CDK5R1 Q15078 1/20 0.32
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
SLC6A3 Q01959 1/20 0.31
GHSR Q92847 1/20 0.30
CCNB2 O95067 1/20 0.30
PRKCG P05129 1/20 0.30
PRKCB P05771 1/20 0.30
CDK1 P06493 1/20 0.30
PDGFRB P09619 1/20 0.30
CCNB1 P14635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8559801 0.89 SLC6A2 (0.35) KDM4EALDH1A1HPGDHSD17B10MAPK10
SCHEMBL8557618 0.88
SCHEMBL8559639 0.79
SCHEMBL8356651 0.70 KDM4E (0.43) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL10719303 0.69 KDM4E (0.40) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL23142622 0.69 KDM4E (0.42) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL4469733 0.69 KDM4E (0.42) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL2247260 0.69 KDM4E (0.42) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL5312977 0.69 KDM4E (0.42) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL8555433 0.68 PRKCG (0.39) KDM4EALDH1A1HPGDHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575954-B1 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process MEDIOLANUM FARMACEUTICI SRL (IT) 1998-09-02 EP disclosed
US-5424451-A Used as cholinesterase activity inhibitors MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1995-06-13 US disclosed
US-5302593-A Aminoalkylcarbamic esters of eseroline suitable for use as chlorinesterase activity inhibitors MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1994-04-12 US disclosed
EP-0575954-A1 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1993-12-29 EP disclosed